These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 9386177)
1. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Ménard J; Campbell DJ; Azizi M; Gonzales MF Circulation; 1997 Nov; 96(9):3072-8. PubMed ID: 9386177 [TBL] [Abstract][Full Text] [Related]
2. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Makino N; Sugano M; Otsuka S; Hata T Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375 [TBL] [Abstract][Full Text] [Related]
4. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats. van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318 [TBL] [Abstract][Full Text] [Related]
5. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats. Richer C; Bruneval P; Ménard J; Giudicelli JF Hypertension; 1998 Feb; 31(2):692-8. PubMed ID: 9461242 [TBL] [Abstract][Full Text] [Related]
6. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat. Grima M; Ingert C; Michel B; Barthelmebs M; Imbs JL Clin Exp Hypertens; 1997; 19(5-6):671-85. PubMed ID: 9247747 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats. Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466 [TBL] [Abstract][Full Text] [Related]
8. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system. Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the acute hypotensive effects of renin inhibition, converting enzyme inhibition, and angiotensin II antagonism in rats. Wood JM; Mah SC; Schnell C J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S60-4. PubMed ID: 1705630 [TBL] [Abstract][Full Text] [Related]
11. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat. Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107 [TBL] [Abstract][Full Text] [Related]
12. Differential response of angiotensin peptides in the urine of hypertensive animals. Yamada K; Iyer SN; Chappell MC; Brosnihan KB; Fukuhara M; Ferrario CM Regul Pept; 1999 Mar; 80(1-2):57-66. PubMed ID: 10235635 [TBL] [Abstract][Full Text] [Related]
13. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats. Mizuno K; Niimura S; Katoh K; Fukuchi S Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847 [TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648 [TBL] [Abstract][Full Text] [Related]
15. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218 [TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of dual blockade of the renin-angiotensin system in spontaneously hypertensive rats: influence of salt. Richer-Giudicelli C; Domergue V; Gonzalez MF; Messadi E; Azizi M; Giudicelli JF; Ménard J J Hypertens; 2004 Mar; 22(3):619-27. PubMed ID: 15076169 [TBL] [Abstract][Full Text] [Related]
17. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological demonstration of the additive effects of angiotensin-converting enzyme inhibition and angiotensin II antagonism in sodium depleted healthy subjects. Azizi M; Guyene TT; Chatellier G; Ménard J Clin Exp Hypertens; 1997; 19(5-6):937-51. PubMed ID: 9247766 [TBL] [Abstract][Full Text] [Related]
19. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension. Kalliovalkama J; Kähönen M; Tolvanen JP; Wu X; Voipio J; Pekki A; Doris PA; Ylitalo P; Pörsti I Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105 [TBL] [Abstract][Full Text] [Related]
20. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats. Schnecko A; Witte K; Lemmer B J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]